Galaxy Medicare share price
NSE: GMLHealthcare Equipment & Supplies
Last close ₹18.05down ₹0.95 (5.00%)
Share price at the NSE close on 23 Oct 2026. Previous close ₹19.00.
52-week range of traded prices to 23 Oct 2026
₹15.15Low, 5 Mar 2026₹23.80High, 29 Dec 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹27 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 21 Jul 2026
- 8.0
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 21 Jul 2026
- 0.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 3.88%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 21 Jul 2026
- 8.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 21 Jul 2026
- 0.10
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 8,00075.0% delivered
Results
Standalone; ₹ crore, the charts by years to March, the table by half year.Half-yearly results
Half year to Mar 2026, against the half year beforeFiled 21 Jul
- RevenueRevenue. The pill is the change in revenue against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹21 Crup 13.56%
- Net profitNet profit. The pill is the change in net profit against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹1.40 Crdown 30.77%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 6.6%
Revenue by year
Net profit by year, a loss in red
| ₹ crore | Sep 2025Filed 10 Dec | Mar 2026Filed 21 Jul |
|---|---|---|
| Revenue | 18.7 | 21.3 |
| Net profit | 2.0 | 1.4 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 10.8% | 6.6% |
Standalone. The 2 half years from Sep 2025, the first on record. The latest is shaded.
Business segments
In the year to Mar 2026 the company reports one business segment, Manufacturing of POP Bandage, Surgical Dressings & Adhessive Bandages, which carries all its revenue.
Valuation
Today, against the company's own history. Not shown, EV/EBITDA: a period of the last twelve months does not state its operating profit.PE ratio and valuation history
Price to bookPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
At or below today's level on 38% of 172 trading days since Dec 2025.
LowestHighest
Its median0.7Industry median2.5
Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.
At or below today's level on 95% of 205 trading days over the last year.
LowestHighest
Its median1.87%Industry median0.28%
Peers and competitors
Medical Equipment & Supplies, 27 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Galaxy Medicare in market cap. 2 companies in the table last traded before then: their rows are priced on their last trade.
Where the company sits among the companies nearest its size
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Choksi AsiaCHOKSI | 113 | 21.8 | 2.7 | 16.0 | +21.4% | – | 13.1% | 14.7% | 0.00% |
 Shree PacetronixSHREEPAC | 59 | 18.3 | 3.3 | 11.5 | +22.5% | +210.4% | 20.3% | 21.8% | 0.00% |
 Mohini Health & HygieneMHHL | 52 | – | 0.6 | – | −13.9% | −382.3% | −17.2% | – | 0.00% |
 Amkay ProductsAMKAY | 46 | 20.0 | 1.8 | – | +9.5% | −30.8% | 9.2% | – | 0.00% |
 Royal SenseROYAL | 37 | 5.2 | 0.9 | – | +67.5% | +13.0% | 21.0% | – | 0.00% |
 GKB OphthalmicsGKB | 30 | 9.3 | 0.6 | 3.6 | +29.9% | – | 6.2% | 10.5% | 0.00% |
 Centenial Surgical SutureCSURGSU | 25 | – | 0.9 | 5.8 | +6.7% | – | −4.8% | 5.3% | 0.00% |
 Transpact EnterprisesTRANSPACT | 4 | 44.4 | 7.2 | – | – | – | 17.6% | – | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.Dividend history and dates
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up.Highest ₹0.70 a share, year to Mar 2026.
| Ex-date | Type | Per share |
|---|---|---|
| 11 Sep 2026 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹0.35 |
| 17 Dec 2025 | Interim | ₹0.35 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.Share news and announcements
Sep 2026
2 Sep · Corporate action
Aug 2026
Jul 2026
Galaxy Medicare share price by year
Each calendar year to 2025.Galaxy Medicare share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 21.60 | – | 51.30 | 18.55 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2025 is from its first session, 17 Sep 2025.
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on NSE.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 23 Oct 2026 | 18.10 | 18.10 | 18.05 | 18.05 | 18.06 | 8,000 | 75.0% |
| 21 Oct 2026 | 18.25 | 19.00 | 18.10 | 19.00 | 18.29 | 12,000 | 66.7% |
| 19 Oct 2026 | 18.50 | 19.05 | 18.50 | 19.05 | 18.68 | 6,000 | 100.0% |
| 16 Oct 2026 | 18.90 | 18.90 | 17.80 | 18.80 | 18.50 | 6,000 | 100.0% |
| 15 Oct 2026 | 18.05 | 19.05 | 18.00 | 18.10 | 18.50 | 22,000 | 81.8% |
| 14 Oct 2026 | 19.05 | 19.05 | 18.90 | 18.90 | 18.98 | 4,000 | 100.0% |
| 13 Oct 2026 | 18.20 | 18.25 | 17.00 | 18.25 | 17.82 | 6,000 | 100.0% |
| 12 Oct 2026 | 16.35 | 17.45 | 16.15 | 17.45 | 17.01 | 20,000 | 70.0% |
| 8 Oct 2026 | 16.65 | 16.65 | 16.65 | 16.65 | 16.65 | 2,000 | 100.0% |
| 7 Oct 2026 | 17.00 | 17.00 | 16.50 | 16.65 | 16.72 | 12,000 | 100.0% |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- Galaxy Medicare Limited
- NSE symbol
- GML
- ISIN
- INE09A801015
- Industry
- Healthcare Equipment & Supplies
- Listed
- Sep 2025
- Face value
- ₹10